118 related articles for article (PubMed ID: 14534700)
1. Pentoxifylline promotes development of murine colon adenocarcinoma-derived metastatic tumors in liver.
Grzela T; Lazarczyk M; Niderla J; Golab J; Lazarczyk MA; Skopinski P
Oncol Rep; 2003; 10(6):1805-9. PubMed ID: 14534700
[TBL] [Abstract][Full Text] [Related]
2. Differential influence of pentoxifylline on murine colon adenocarcinoma- and melanoma-derived metastatic tumor development in lungs.
Lazarczyk M; Grzela T; Niderla J; Lazarczyk MA; Milewski L; Dziunycz P; Skopinski P; Golab J
Oncol Rep; 2004 May; 11(5):1121-5. PubMed ID: 15069556
[TBL] [Abstract][Full Text] [Related]
3. Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
Lozonschi L; Sunamura M; Kobari M; Egawa S; Ding L; Matsuno S
Cancer Res; 1999 Mar; 59(6):1252-8. PubMed ID: 10096556
[TBL] [Abstract][Full Text] [Related]
4. CpG ODN, Toll like receptor (TLR)-9 agonist, inhibits metastatic colon adenocarcinoma in a murine hepatic tumor model.
Kim IY; Yan X; Tohme S; Ahmed A; Cordon-Cardo C; Shantha Kumara HM; Kim SK; Whelan RL
J Surg Res; 2012 May; 174(2):284-90. PubMed ID: 21324492
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline inhibits leukocyte infiltration and splenocyte cytotoxicity against murine colon adenocarcinoma.
Lazarczyk M; Grzela T; Niderla J; Golab J; Korczak-Kowalska G; Oldak M; Skopinski P
Oncol Rep; 2003; 10(4):839-43. PubMed ID: 12792732
[TBL] [Abstract][Full Text] [Related]
6. A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells.
Emura T; Murakami Y; Nakagawa F; Fukushima M; Kitazato K
Int J Mol Med; 2004 Apr; 13(4):545-9. PubMed ID: 15010854
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.
Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K
Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799
[TBL] [Abstract][Full Text] [Related]
8. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
[TBL] [Abstract][Full Text] [Related]
10. Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470.
Tanaka T; Konno H; Matsuda I; Nakamura S; Baba S
Cancer Res; 1995 Feb; 55(4):836-9. PubMed ID: 7531615
[TBL] [Abstract][Full Text] [Related]
11. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
[TBL] [Abstract][Full Text] [Related]
12. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice.
Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T
Cancer Gene Ther; 2004 Jun; 11(6):419-30. PubMed ID: 15017381
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
[TBL] [Abstract][Full Text] [Related]
14. Neonatal inoculation with the protein-bound polysaccharide PSK increases resistance of adult animals to challenge with syngeneic tumor cells and reduces azoxymethane-induced precancerous lesions in the colon.
Matsunaga K; Iijima H; Kobayashi H
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1313-22. PubMed ID: 11142416
[TBL] [Abstract][Full Text] [Related]
15. Low-dose heparin treatment does not inhibit SW480 human colon cancer growth and metastasis in vivo.
Antachopoulos CT; Gagos S; Iliopoulos DC; Karayannacos PE; Tseleni-Balafouta S; Alevras P; Koundouris C; Skalkeas GD
In Vivo; 1996; 10(5):527-31. PubMed ID: 8899433
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-binding protein 3 inhibits growth of experimental colocarcinoma.
Kirman I; Poltoratskaia N; Sylla P; Whelan RL
Surgery; 2004 Aug; 136(2):205-9. PubMed ID: 15300181
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of a model of liver metastasis using human colon cancer HCT-116 cells.
Ishizu K; Sunose N; Yamazaki K; Tsuruo T; Sadahiro S; Makuuchi H; Yamori T
Biol Pharm Bull; 2007 Sep; 30(9):1779-83. PubMed ID: 17827739
[TBL] [Abstract][Full Text] [Related]
18. Direct effects of octreotide, galanin and serotonin on human colon cancer cells.
El-Salhy M; Starefeldt A
Oncol Rep; 2003; 10(6):1723-8. PubMed ID: 14534685
[TBL] [Abstract][Full Text] [Related]
19. Possible effect of pneumoperitoneum on the spreading of colon cancer tumor cells.
Chen WS; Lin W; Kou YR; Kuo HS; Hsu H; Yang WK
Dis Colon Rectum; 1997 Jul; 40(7):791-7. PubMed ID: 9221854
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice.
Mizuno Y; Naoi T; Nishikawa M; Rattanakiat S; Hamaguchi N; Hashida M; Takakura Y
J Control Release; 2010 Jan; 141(2):252-9. PubMed ID: 19778560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
